summary
Introduced
02/07/2025
02/07/2025
In Committee
03/26/2026
03/26/2026
Crossed Over
02/25/2026
02/25/2026
Passed
Dead
Introduced Session
104th General Assembly
Bill Summary
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.
AI Summary
This bill amends various Illinois Acts to replace the terms "epinephrine auto-injector" and "epinephrine injector" with the broader term "FDA approved epinephrine delivery device or product," which refers to any device or product approved by the U.S. Food and Drug Administration (FDA) for administering epinephrine, a life-saving medication for severe allergic reactions (anaphylaxis). This change aims to modernize terminology and encompass a wider range of approved devices. Additionally, the bill renames the "Epinephrine Injector Act" to the "FDA Approved Epinephrine Delivery Device or Product Act" to reflect this updated terminology. The bill also makes conforming changes in laws related to the Illinois State Police, police training, schools, insurance coverage, medical practice, and food and drug regulations to ensure consistency with the new terminology.
Committee Categories
Health and Social Services
Sponsors (9)
Suzy Glowiak Hilton (D)*,
Joyce Mason (D)*,
Dee Avelar (D),
Harry Benton (D),
Martha Deuter (D),
Camille Lilly (D),
Michelle Mussman (D),
Omar Williams (D),
Janet Yang Rohr (D),
Last Action
Referred to Assignments (on 03/26/2026)
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...